Piramal Pharma Limited — Important, 01-04-2025: Commencement of commercial production/operations

Piramal Pharma Limited has announced a board meeting to discuss the commencement of commercial production of Sevoflurane at its Digwal facility in Telangana, India. This expansion enhances production capacity beyond its existing facility in Bethlehem, Pennsylvania, USA, positioning the company to capitalize on Inhalation Anesthesia opportunities in both the USA and other global markets. This development could positively influence investor sentiment by signaling growth and diversification of product offerings, potentially driving future revenue growth and strengthening its competitive edge in the sector.